Authors
Sally Aman Nasution, Lusiani Lusiani, Michelle Frastica, Ikhwan Rinaldi, Lie Khie Chen, Syahidatul Wafa, Andhika Rachman
Published in
Acta medica Indonesiana. Volume 58. Issue 3. Pages 386-392.
Abstract
This study to validate the TIMI (Thrombolysis in Myocardial Infarction) core and also assess the validity of a modified TIMI score that includes three additional variables from primary percutaneous coronary intervention (PPCI) findings: left ventricular ejection fraction based on echocardiography post-PPCI, TIMI flow, and the number of lesions in a population of STEMI (ST-elevation myocardial infarction) patients who underwent PPCI at Cipto Mangunkusumo National Hospital, with a focus on predicting 30-day mortality. This is the first study to validate the TIMI score among STEMI patients who underwent PPCI at Cipto Mangunkusumo National Hospital. This study aimed to develop a modified TIMI score with enhanced ability to predict 30-day mortality among STEMI patients at Cipto Mangunkusumo National Hospital following PPCI.
Among 230 study subjects, the 30-day mortality rate for the patients post-PPCI was 10%. There was no significant association between ejection fraction based on echocardiography after PPCI, TIMI flow, or the number of lesions and 30-day mortality post-PPCI in the STEMI patients. The discrimination performance of the TIMI score in predicting 30-day mortality post-PPCI was AUC (Area Under the Curve) 0.901, with good calibration.
The performance of the TIMI score in terms of predicting 30-day mortality after PPCI in STEMI patients at Cipto Mangunkusumo National Hospital was excellent (AUC 0.901, 95% CI 0.849-0.952), with good calibration. TIMI score can predict the 30-day mortality rate among STEMI patients undergoing PPCI.
PMID:
42845082
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0